Eric Cantor, Vice Chairman at Moelis & Co., will become the next CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA). PhRMA is a prominent trade group. Endpoints News reported the move on September 29, 2026.
Cantor, a former U.S. House Majority Leader, will depart his senior role at Moelis. He will lead PhRMA, an influential lobbying organization. His departure marks a significant change for Moelis's leadership ranks. Cantor possesses extensive political and business connections.